Procedures & recovery · patient guide

Menopause and rheumatic disease in China: what to check

Menopause can change the pattern of rheumatoid arthritis, lupus and other rheumatic conditions, but it does not follow one predictable course. The useful preparation is a clear record of your diagnosis, current medicines, recent disease activity, bone health and menopause symptoms, plus written questions for the treating rheumatologist. In China, a specialist should confirm how your joint disease and menopause symptoms interact before anything is changed.

Go to the practical guidance ↓
AI illustration: A doctor in a white coat consulting with a patient at a table in a well-lit room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Why menopause matters in rheumatic disease

Menopause is a hormonal transition, not a disease, and its timing varies widely between women. In rheumatic disease, the relevant question is not whether menopause causes a particular condition, but how the hormonal shift, changing sleep, bone loss and altered body composition interact with an existing inflammatory disease and its treatment.

Established knowledge supports a few practical points. Oestrogen loss after menopause accelerates bone loss, which matters for anyone who has taken glucocorticoids or has had reduced physical activity during flares. Some rheumatic conditions change in activity around the transition, but the direction and size of that change differ between people and between diseases. Rheumatoid arthritis, lupus and other connective tissue diseases each behave differently, and some medicines affect bone, blood pressure or infection risk independently of menopause.

That means a useful consultation is not a single question about hormones. It is a review of your disease activity, your current treatment, your fracture risk and your menopause symptoms together. The treating rheumatologist and, where needed, a gynaecologist or endocrinologist should decide what is appropriate for you.

What to record before you ask for an opinion

A records-based review is only as good as the information supplied. Start with the confirmed diagnosis and the date it was made, including any specific antibodies or imaging that supported it. List every medicine you take, with the dose and how long you have taken it, including glucocorticoids, conventional disease-modifying drugs, biologics, pain relief and any supplements. Note any medicine you have stopped and why.

Then describe the pattern of your disease over the past year rather than a single bad week. Which joints are affected, whether morning stiffness has changed, whether you have had flares, and what your most recent inflammatory markers showed. Include any recent bone density result, fracture history and vitamin D or calcium records if you have them.

For menopause, note the date of your last period if known, whether periods have become irregular, and which symptoms bother you most, such as hot flushes, night sweats, sleep disturbance, mood change or vaginal dryness. Record whether these symptoms started before or after a change in your rheumatic medicines, because that timing is clinically useful.

Bring the actual reports, not only a summary. If records are in another language, ask the receiving team what translation or interpretation they require. Our team can help identify what is missing from a first summary, but the clinical assessment belongs to the treating specialists.

  • Confirmed rheumatic diagnosis and date
  • Current medicines with doses and duration
  • Recent disease activity and laboratory results
  • Bone density, fracture history and calcium or vitamin D records
  • Menopause symptom pattern and timing relative to treatment changes

Hormone therapy and rheumatic disease: what to ask

Hormone therapy is used for menopause symptoms, and its suitability depends on your personal risk profile, your type of rheumatic disease and your current medicines. Some conditions, particularly lupus with certain antibody patterns or a history of clotting, raise questions that a gynaecologist and rheumatologist should consider together. This is not a decision to make from a general article.

A useful question is not simply whether hormone therapy is safe for rheumatoid arthritis. Ask instead what your treating team needs to know before advising you: your blood pressure, clotting history, migraine pattern, liver health and any antibody results that affect risk. Ask whether non-hormonal options for hot flushes are appropriate given your medicines and your disease.

If you are already taking hormone therapy and are considering care in China, bring the exact product, dose and duration. Do not stop or change it before speaking to a clinician who knows your history. Cross-border supply and prescribing rules differ, so ask the treating provider how a continuation would be handled rather than assuming a product is available.

The same caution applies to herbal or over-the-counter menopause products. Some interact with medicines or affect liver tests, and their content is not always standardised. Tell the rheumatologist what you take, even if you consider it minor.

Bone health and fracture risk deserve a separate conversation

Bone loss after menopause is a well-established process, and rheumatic disease can add to it through inflammation, reduced activity and glucocorticoid exposure. A rheumatology review is a reasonable place to raise bone health, but the assessment and any treatment decision should be individual.

Ask whether your fracture risk has been assessed, what your most recent bone density result showed, and whether your calcium and vitamin D intake is adequate. Ask how long you have taken glucocorticoids and whether your treating team has a plan for the lowest effective dose. These are questions for your clinicians, not instructions to change anything yourself.

Falls matter as much as bone density. If stiffness, pain or balance problems affect your walking, mention this, because exercise and physiotherapy advice may need to be adapted. A physiotherapist working with your rheumatology team can advise on safe activity, but the receiving clinician should make the final judgement about what suits you.

Planning a rheumatology consultation in China

China has public tertiary hospitals and private international hospitals, and both can be routes for a rheumatology consultation. The right choice depends on your diagnosis, the complexity of your case and your language and practical needs. A coordinator can help match your request to a suitable specialist and prepare the visit, but the hospital decides whether it will accept your case and what assessment is appropriate.

Before travelling, confirm the appointment in writing and ask what records the department wants in advance. Ask whether interpretation will be available, who will provide it, and whether the consultation includes a review of your imaging or only your laboratory results. Ask how a follow-up opinion would be arranged if further tests are needed.

If your case is complex or crosses specialties, a review involving rheumatology and another relevant specialty may be discussed. The scope and any fee should be agreed before that review begins. A remote records-based opinion is optional and is not a prerequisite for every appointment, nor does it establish final eligibility for any treatment.

For anyone whose main question is menopause management rather than the rheumatic disease itself, say so clearly at the start. The receiving team can then decide whether a gynaecology or endocrinology opinion should be part of the plan.

What a first enquiry should and should not include

An initial enquiry is free and does not require buying a proxy consultation. A short summary is enough to begin: your main question, your confirmed diagnosis, your current medicines and the records you can share. Do not send passport numbers, card details or a complete medical archive through an article form.

After first contact, our team can explain how to share records securely and what information would help a specialist understand your case. We provide information and non-clinical coordination; diagnosis, prescribing, suitability and hospital acceptance remain with the treating clinicians. Hospital fees and our coordination fees are separate, and any estimate should be confirmed in writing for your individual plan.

The practical next step is to write down your two or three most important questions, gather the records that support them, and ask for a review of what you have. That gives the treating team a clearer basis for advice than a long list of unrelated concerns.

Sources & scope of this guide

References and official service information relevant to this guide.

    This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.